作者: Ian A. Mendez , Ryan J. Gilbert , Jennifer L. Bizon , Barry Setlow
DOI: 10.1007/S00213-012-2777-Y
关键词: Nicotinic agonist 、 Cholinergic 、 Addiction 、 Psychology 、 Perseveration 、 Neuroscience 、 Impulsivity 、 Schizophrenia 、 Muscarinic acetylcholine receptor 、 Attention deficit hyperactivity disorder
摘要: Rationale Alterations in cost–benefit decision making accompany numerous neuropsychiatric conditions, including schizophrenia, attention deficit hyperactivity disorder, and addiction. Central cholinergic systems have been linked to the etiology and/or treatment of many these but little is known about role signaling making.